Discovery of novel conformationally restricted diazocan peptidomimetics as inhibitors of interleukin-1beta synthesis.

Kofi A Oppong; Christopher D Ellis; Michael C Laufersweiler; Steven V O'Neil; Yili Wang; David L Soper; Mark W Baize; John A Wos; Biswanath De; Gregory K Bosch

doi:10.1016/j.bmcl.2005.06.050

Discovery of novel conformationally restricted diazocan peptidomimetics as inhibitors of interleukin-1beta synthesis.

Identifier:nobleid.org/w1/20260515/DF7DB218

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/DF7DB218.svg?ark=w1%2F20260515%2FDF7DB218)](https://nobleid.org/work/w1/20260515/DF7DB218)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Kofi A Oppong

Christopher D Ellis

Michael C Laufersweiler

Claim authorship of this work

Discovery of novel conformationally restricted diazocan peptidomimetics as inhibitors of interleukin-1beta synthesis.

Identifier:nobleid.org/w1/20260515/DF7DB218

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/DF7DB218.svg?ark=w1%2F20260515%2FDF7DB218)](https://nobleid.org/work/w1/20260515/DF7DB218)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Kofi A Oppong

Christopher D Ellis

Michael C Laufersweiler

Claim authorship of this work